You have the best clinical evidence. The worst content visibility.
We write and publish 110–180 pieces of clinically sourced, AI-optimized content on your website per year. 70% requires zero MLR approval. Your clinical evidence finally becomes visible to buyers, clinicians, and AI systems.
The way buyers find medical
devices has fundamentally changed.
Content marketing has been the dominant growth strategy in every B2B industry for a decade. Life sciences is the last holdout. The companies that figure this out first will own their categories.
Organic leads close at 14.6% vs. 1.7% for outbound
Source: First Page Sage, B2B Healthcare Sales Data
The regulatory paradox: your compliance discipline is actually your content advantage.
AI models reward exactly what regulated companies produce: structured, evidence-backed, clearly sourced content. The same discipline that slows you down in MLR review makes your non-promotional content rank higher than wellness blogs and competitor marketing pages. You just need to produce enough of it.
The evidence exists.
Nobody can find it.
Your company publishes 8–12 content pieces per year. Medtronic publishes thousands. Wellness blogs publish hundreds daily. And AI answers cite whoever has the most structured, published clinical content.
Your Clinical Evidence
What Google & AI Show Instead
We write clinically sourced articles and publish them on your website. Continuously.
Not a SaaS tool you have to learn. Not a consulting deck. We produce publication-ready clinical content grounded in real data from PubMed, FDA databases, ClinicalTrials.gov, and 12 other sources — reviewed by humans, optimized for search and AI, and published on your domain under your brand.
One engine. Two content tracks.
Radically different approval paths.
Branded content goes through MLR. Non-promotional content doesn't have to. That's not a loophole — it's FDA guidance.
Your product. Your claims. MLR-reviewed.
Product evidence pages, cleared indication landing pages, reimbursement guides, and application notes that reference your device by name. These require MLR review — we streamline the process, but we don't skip it.
The category. The science. Zero MLR.
Disease-state education, clinical guideline summaries, technology explainers, health economics, research summaries, and more — all published under your brand without ever mentioning your product by name. FDA guidance confirms this is not promotional.
FDA Jan 2025 Final Guidance: “Drug and Device Manufacturer Communications That Are Consistent With the FDA-Required Labeling” — confirms non-promotional, disease-state content does not require MLR review.
Real articles. Your brand.
Published on your domain.
These are the kinds of articles we publish on your website — clinically sourced from public databases, optimized for search and AI, and published under your company name. No product mentioned. No MLR required.
Your name. Your authority.
FDA guidance is clear: company identification is not product promotion. Medtronic, Pfizer, Boston Scientific — every major life sciences company puts their name and logo on educational content. You should too.
The only line that matters.
The distinction isn't whether your company is visible — it's whether your product is named. Keep the company front and center. Keep the product out of the content.
1 article becomes 20+
Every well-researched article multiplies into derivative content across formats, audiences, and depth levels — all from the same foundational research, all non-promotional.
1 PubMed study. 6 LinkedIn posts. 6 audiences.
We took one real study and ran it through the Content Engine. Same data, six completely different messages — each tailored to what that audience actually cares about.
Robotic TKA vs Conventional TKA: A Nationwide Database Study
Ofa SA, Ross BJ, Flick TR, Patel AH, Sherman WF • Arthroplasty Today, 2020
3 product lines × 5–15 branded pieces + 2 therapeutic areas × 30–50 non-promotional pieces = a content library that dominates search and AI visibility in your category.
We know exactly where
the line is.
Every piece is automatically classified and routed through the correct review path. Scale without compliance risk.
Safe — No MLR Required
Requires MLR Review
See what 110–180 pieces looks like for your business.
Tell us your product lines and therapeutic areas — we'll send you a custom content plan with article titles, categories, and volume breakdown within 48 hours. Free.
From onboarding to
published in weeks.
A repeatable process that turns clinical data into publication-ready content — continuously.
Onboarding
1–2 weeksWe map your product lines, therapeutic areas, and competitive landscape. You share clinical evidence packages and regulatory constraints. We build your content taxonomy.
AI Generation
OngoingOur pipeline pulls from 15+ clinical data APIs — PubMed, FDA, ClinicalTrials.gov, CMS, and more — and generates draft content across all 10 categories, structured for SEO and AI search.
Human Review
1–3 days per batchEvery article passes through clinical review for accuracy, regulatory review for compliance, and editorial review for readability. Non-promotional content skips MLR entirely.
Publish & Monitor
ContinuousContent publishes to your domain. We monitor rankings, AI citations, and engagement. Performance data feeds back into the pipeline to optimize future content.
What you get each month
You have four choices.
Three of them don't scale.
Do nothing
Your competitors build AI authority while you stay invisible. Every month you wait, the gap widens.
Hire a medical writer
One person can't cover 10 content categories, SEO optimization, AI structuring, and performance monitoring.
Use an agency
Enterprise agencies (EVERSANA, Klick) charge enterprise prices. Built for top-20 pharma, not mid-market.
VayoMed Content Engine
Clinically sourced from 15+ APIs. Human-reviewed. Published on your domain. Performance monitored.
The 6–12 stakeholders
who decide if you get purchased.
Hospital purchasing involves VAC members, procurement, engineers, and clinicians — all researching online before your rep ever gets a meeting.
VAC Members
Clinical evidence summaries, technology comparisons, and health economics data for evaluation meetings.
Procurement Officers
Cost-effectiveness analyses, total cost of care, reimbursement coding guides, and contract benchmarks.
Biomedical Engineers
Technical specifications, workflow integration guides, and safety/compatibility documentation.
Clinicians
Procedure-specific evidence, guidelines summaries, and real-world outcomes data.
Enterprise-grade content.
Mid-market pricing.
Medtronic publishes 1,000+ clinical articles. Boston Scientific has evidence pages for every product line. Philips engages 100K+ professionals through content. They have $100M+ marketing budgets. You don't need one.
15+ Clinical Data Sources
PubMed, FDA, ClinicalTrials.gov, CMS, GUDID, CDC WONDER, NHANES, AHRQ, WHO, Cochrane, MAUDE, SEER, and more — integrated, cross-referenced, and continuously updated.
FDA Compliance Built In
Our system encodes the branded/unbranded bright line from FDA Jan 2025 guidance. Every piece is automatically classified and routed through the correct review path.
Content + Monitoring Loop
Published content feeds into our Brand Monitor. We track which pieces rank in Google, get cited by AI, and drive engagement — then optimize based on real performance data.
First to publish wins
the category.
AI gives one answer. Google shows one AI Overview. The company with the most published clinical content in your category owns that answer. Right now, it's probably not you.
Free content plan with article titles and volume breakdown — delivered in 48 hours.
No long-term contracts. No lock-in. Cancel anytime.